Menu

• Ask a Health Expert about ALPHA-1 ANTI-TRYPSIN DEFICIENCY
• Post Your Side Effect related to ALPHA-1 ANTI-TRYPSIN DEFICIENCY
• ALPHA-1 ANTI-TRYPSIN DEFICIENCY and FDA Warnings
• ALPHA-1 ANTI-TRYPSIN DEFICIENCY in Patients Wiki
• Report ALPHA-1 ANTI-TRYPSIN DEFICIENCY in Drug Side Effect Survey

ALPHA-1 ANTI-TRYPSIN DEFICIENCY side effect

What is ALPHA-1 ANTI-TRYPSIN DEFICIENCY ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Lamictal Side Effects Report #5405287-4
Physician from IRELAND reported LAMICTAL problem on July 26, 2007. Male patient, weighting 3.97 lb, was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: alpha-1 anti-trypsin deficiency, blood bilirubin increased, cholestasis, gamma-glutamyltransferase increased, hepatic enzyme increased, hepatitis, hyperbilirubinaemia, . LAMICTAL dosage: unknown. Patient was hospitalized. Patient recovered.

Lamictal Side Effects Report #5409725-2
LAMICTAL problem was reported by a Physician from IRELAND on Aug 07, 2007. Male patient, weighting 3.97 lb, was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: alpha-1 anti-trypsin deficiency, blood bilirubin increased, cholestasis, gamma-glutamyltransferase increased, hepatic enzyme increased, hepatitis, hyperbilirubinaemia, . LAMICTAL dosage: unknown. Patient was hospitalized. Patient recovered.

Levbid Side Effects Report #5784237-5
Consumer or non-health professional from UNITED STATES reported LEVBID problem on June 19, 2008. Female patient, weighting 211.0 lb, was diagnosed with gastrooesophageal reflux disease, hernia, oesophageal spasm and was treated with LEVBID. After drug was administered, patient experienced the following problems/side effects: alpha-1 anti-trypsin deficiency, bone pain, chest pain, renal impairment, ureteral disorder, . LEVBID dosage: unknown. During the same period patient was treated with NULEV HYOSCYAMINE SULPHATE, NULEV HYOSCYAMINE SULPHATE, NULEV HYOSCYAMINE SULPHATE. Patient recovered.

Humira Side Effects Report #5747898-2
HUMIRA problem was reported by a Health Professional from SWEDEN on May 15, 2008. Male patient, 48 years of age, was diagnosed with rheumatoid arthritis and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: alpha-1 anti-trypsin deficiency, benign respiratory tract neoplasm, emphysema, inflammation, pleural fibrosis, pulmonary fibrosis, . HUMIRA dosage: 40 MG WHEN NEEDED. During the same period patient was treated with ACETAMINOPHEN, TRAMADOL, LEFLUNOMIDE. Patient was hospitalized. Patient recovered.


Lamictal Side Effects Report #5337248-8
Physician from IRELAND reported LAMICTAL problem on May 16, 2007. Male patient, weighting 3.97 lb, was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: alpha-1 anti-trypsin deficiency, blood bilirubin increased, cholestasis, gamma-glutamyltransferase increased, hepatic enzyme increased, hepatitis, hyperbilirubinaemia, . LAMICTAL dosage: unknown. Patient was hospitalized. Patient recovered.

Vytorin Side Effects Report #5446412-9
VYTORIN problem was reported by a Physician from UNITED STATES on Aug 31, 2007. Female patient, 61 years of age, was diagnosed with blood cholesterol and was treated with VYTORIN. After drug was administered, patient experienced the following problems/side effects: acute hepatic failure, alpha-1 anti-trypsin deficiency, blood creatine phosphokinase increased, hepatocellular damage, renal failure, . VYTORIN dosage: unknown. During the same period patient was treated with PRILOSEC, SYNTHROID, MICARDIS, VIVELLE, NEURONTIN, ZOLOFT. Patient was hospitalized and became disabled. Patient died on 08/31/2007.

Vytorin Side Effects Report #5426258-8
Physician from UNITED STATES reported VYTORIN problem on Aug 21, 2007. Female patient, 61 years of age, was diagnosed with blood cholesterol and was treated with VYTORIN. After drug was administered, patient experienced the following problems/side effects: acute hepatic failure, alpha-1 anti-trypsin deficiency, blood creatine phosphokinase increased, hepatocellular damage, . VYTORIN dosage: unknown. During the same period patient was treated with PRILOSEC, SYNTHROID, MICARDIS, VIVELLE, NEURONTIN, ZOLOFT. Patient was hospitalized and became disabled. Patient recovered.